Tradestie Institutional Equity Comparison Engine

ENSC vs BFRI โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ENSC Overall Edge

ENSC Captures Institutional Edge (2โ€“1 Pillars ยท 5โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ensysce Biosciences, Inc. Common Stock (ENSC) driven by superior Valuation, Momentum & Technical while BFRI counters with relative strength in Growth & Margin. Fundamentally, ENSC trades at 0.8x Forward P/E with -281.3% operating margin (-15.1% YoY revenue) versus BFRI at 13.0x Forward P/E and -12.6% operating margin (+29.8% YoY). In options structure, ENSC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against BFRI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner ENSC
ENSC 0.8x vs BFRI 13.0x Fwd P/E
Growth & Margin Winner BFRI
Op Margin -281.3% vs -12.6% ยท YoY -15.1% vs +29.8%
Momentum & Technical Winner ENSC
1Y -80.3% vs -34.5% ยท 52W Pos 8% vs 0%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
ENSC NASDAQ
Ensysce Biosciences, Inc. Common Stock
Pharmaceutical Preparations
$0.36
-0.17% 1D
Market Cap $7.0M
1M Return -29.55%
1Y Return -80.33%
Forward P/E 0.8x
Unified AI Score
53.4 / 100 HOLD
Tech 50.0 Fund 62.0 Flow 50.0 Mom 60.0
BFRI NASDAQ
Biofrontera Inc. Common Stock
Pharmaceutical Preparations
$0.53
-7.02% 1D
Market Cap $10.2M
1M Return -32.14%
1Y Return -34.49%
Forward P/E 13.0x
Unified AI Score
44.0 / 100 HOLD
Tech 25.0 Fund 42.0 Flow 50.0 Mom 59.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ENSC -80.33% BFRI -34.49% Spread: +45.84 pp (BFRI Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period ENSC Revenue BFRI Revenue ENSC Op. Margin BFRI Op. Margin Margin Edge
FY2020 $0M $20M -41.0% -51.0% ENSC
FY2021 $0M $20M -562.7% -104.6% BFRI
FY2022 $0M $30M -959.9% -64.8% BFRI
FY2023 $0M $30M -480.5% -66.6% BFRI
FY2024 $10M $40M -129.2% -46.1% BFRI
FY2025 $10M $40M -202.1% -27.2% BFRI

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ENSC (5) vs BFRI (4)
Institutional Metric ENSC BFRI Criterion Row Winner
Market Capitalization Scale $7.0M $10.2M Larger Scale Tie
Trailing P/E Ratio Valuation 0.8x 13.0x Lower Multiple ENSC
Forward P/E Ratio Valuation 0.8x 13.0x Lower Multiple ENSC
Revenue Growth (YoY) Growth -15.1% +29.8% Higher Growth BFRI
Operating Margin (TTM) Profitability -281.3% -12.6% Higher Margin BFRI
Net Profit Margin Profitability -280.5% -12.7% Higher Margin BFRI
Return on Equity (ROE) Capital Efficiency -1295.1% -988.4% Higher ROE BFRI
52-Week Range Position Momentum 8% ($0โ€“$2) 0% ($1โ€“$2) Stronger Trend ENSC
Beta / 30D Volatility Risk Regime 0.98ฮฒ ยท 79% Vol 1.84ฮฒ ยท 125% Vol Lower Realized Risk ENSC
Unified Institutional Score Composite Signal 53.4 / 100 (HOLD) 44.0 / 100 (HOLD) Higher Composite ENSC

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ENSC vs BFRI Buy Guide
ENSC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ENSC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BFRI UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BFRI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ENSC nor BFRI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.